2012-11-16 13:41:51 - New report provides a comprehensive overview of the US specialty pharmaceutical market
According to the report 'The US Specialty Pharmaceutical Market Report: 2012 Edition' available at:
With the advent of novel technologies, companies operating in the healthcare/pharmaceutical/therapeutic industry are now scaling new heights. Also, this industry is boosted by the rising number of incidences of health related issues emanating from the changing lifestyle and continuously evolving surrounding environment. To address the growing demand for better healthcare options and the unmet needs within the chronic disease segment, respective companies are coming up with new and improved therapies some of which fall within the bounds of specialty pharmaceuticals.
There is no particular definition for specialty pharmaceutical but on the basis of some parameters, it takes into account the following:
● Biotech origin of drugs/plasma derivatives
● Skyrocketing cost of treatment
● Treatment for a chronic condition by specialist
● Patient monitoring and education is required
● Distribution calls for special handling
This report provides a comprehensive overview of the US specialty pharmaceutical market covering various disease segments and the specialty pharmacy market. The specialty pharma realm is intensely competitive with numerous corporations holding the reins of the same.